These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12071403)

  • 21. Validation of the alternating conditional estimation algorithm for estimation of flexible extensions of Cox's proportional hazards model with nonlinear constraints on the parameters.
    Wynant W; Abrahamowicz M
    Biom J; 2016 Nov; 58(6):1445-1464. PubMed ID: 27550754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
    Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative classification based on CT histogram analysis of non-small cell lung cancer: correlation with histopathological characteristics and recurrence-free survival.
    Kawata Y; Niki N; Ohmatsu H; Kusumoto M; Tsuchida T; Eguchi K; Kaneko M; Moriyama N
    Med Phys; 2012 Feb; 39(2):988-1000. PubMed ID: 22320808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
    Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of methods for estimating the attributable risk in the context of survival analysis.
    Gassama M; Bénichou J; Dartois L; Thiébaut AC
    BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition.
    Nieters A; Rohrmann S; Becker N; Linseisen J; Ruediger T; Overvad K; Tjønneland A; Olsen A; Allen NE; Travis RC; Bingham S; Khaw KT; Ardanaz E; Redondo ML; Basterrechea M; Martinez C; Tormo MJ; Rosso S; Tagliabue G; Masala G; Mattiello A; Tumino R; Boeing H; Bergmann M; Kaaks R; Trichopoulou A; Trichopoulos D; Peeters PH; Bueno-de-Mesquita B; Boffetta P; Brennan P; Ferrari P; Neasham D; Lund E; Berglund G; Manjer J; Hallmans G; Johansson I; Vineis P; Riboli E
    Am J Epidemiol; 2008 May; 167(9):1081-9. PubMed ID: 18321867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative risk trees for censored survival data.
    LeBlanc M; Crowley J
    Biometrics; 1992 Jun; 48(2):411-25. PubMed ID: 1637970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified particle swarm optimization algorithm for adaptively configuring globally optimal classification and regression trees.
    Zhou YP; Tang LJ; Jiao J; Song DD; Jiang JH; Yu RQ
    J Chem Inf Model; 2009 May; 49(5):1144-53. PubMed ID: 19366194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data generation for the Cox proportional hazards model with time-dependent covariates: a method for medical researchers.
    Hendry DJ
    Stat Med; 2014 Feb; 33(3):436-54. PubMed ID: 24014094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors.
    Ibrahim EM; Bunyan RF; al-Mulhim FA; al-Nabhan AA; Ibrahim RE
    Acta Haematol; 1996; 96(3):126-34. PubMed ID: 8876608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
    Ding SL; Ko WS; Hwang WS
    J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of PD-1, FOXP3 and CSF-1R Protein Expression on the Prognosis of Patients with Hodgkin's Lymphoma].
    Li XJ; He L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1372-1377. PubMed ID: 30295253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
    Wheeler C; Strawderman M; Ayash L; Churchill WH; Bierer BE; Elias A; Gilliland DG; Antman K; Guinan EC; Eder JP
    J Clin Oncol; 1993 Jun; 11(6):1085-91. PubMed ID: 8099120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis.
    Valera VA; Walter BA; Yokoyama N; Koyama Y; Iiai T; Okamoto H; Hatakeyama K
    Ann Surg Oncol; 2007 Jan; 14(1):34-40. PubMed ID: 17024555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer programs to estimate overoptimism in measures of discrimination for predicting the risk of cardiovascular diseases.
    Mannan HR; McNeil JJ
    J Eval Clin Pract; 2013 Apr; 19(2):358-62. PubMed ID: 22409210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
    Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
    Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood cancers in Chennai, India, 1990-2001: incidence and survival.
    Swaminathan R; Rama R; Shanta V
    Int J Cancer; 2008 Jun; 122(11):2607-11. PubMed ID: 18324630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
    Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.